Cargando…
High prolactin levels in dihydropteridine reductase deficiency: A sign of therapy failure or additional pathology?
We report the case of a 22‐year‐old man with a diagnosis of dihydropteridine reductase (DHPR) deficiency who progressively developed movement disorders and epilepsy. Despite L‐Dopa supplementation the patient continued to show high prolactin levels, with a discrepancy between the neurological clinic...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411106/ https://www.ncbi.nlm.nih.gov/pubmed/34485017 http://dx.doi.org/10.1002/jmd2.12236 |